CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Illumina, Inc. recalls MiSeq Dx Instrument REF and 4 more

Read the official FDA notice

Published
11 Nov 2026
Units affected
5 products
Agency
FDA
Country
United States

The hazard

(Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

MiSeq Dx Instrument REF: DX-410-1001 / 15036706, FOR IN VITRO DIAGNOSTIC USE

VeriSeq Onsite Server V2 REF: 20047000

Illumina DRAGEN Server for NextSeq 550Dx REF: 20086130,

NovaSeq 6000Dx Instrument REF: 20068232, FOR IN VITRO DIAGNOSTIC USE

Nextseq 550Dx Instrument REF: 20005715, FOR IN VITRO DIAGNOSTIC USE

Brand / company
Illumina, Inc.
Codes / lots
All Lots/UDI: 00816270020002 | All Lots/UDI: N/A | All Lots/UDI: N/A | All Lots/UDI:00816270020637 | All Lots/UDI: 00816270020125
Distribution
Worldwide - US Nationwide distribution including in the states and territory of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of AE, AR, AT, AU, BE, BG, CA, CH, CL, CN, CY, CZ, DE, DK, DZ, EG, ES, FI, FR, GB, Ghana, GR, GT, HK, HU, IE, IL, IS, IT, JP, KR, KW, LT, LU, LV, MA, MT, NG, NL, NO, NZ, PE, PH, PL, PT, QA, RO, RU, SA, SE, SG, SI, TH, TR, UA, VN, ZA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.